Icahn’s Fight Opened Door to Actavis Move Past Generics

Paul Bisaro, Actavis Plc’s acquisition-hungry chief executive officer, and Brent Saunders of Forest Laboratories Inc. met for the first time in January at the JPMorgan health-care conference in San Francisco.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.